Mycoplasma genitalium retrospective audit of Northern Territory isolates from 2022.

Humans Mycoplasma genitalium / isolation & purification Northern Territory / epidemiology Mycoplasma Infections / epidemiology Retrospective Studies Prevalence Male Female Adult Anti-Bacterial Agents / pharmacology Drug Resistance, Bacterial Middle Aged Sexually Transmitted Diseases / epidemiology Young Adult Macrolides / pharmacology
Mycoplasma genitalium Northern Territory STI infectious diseases sexually transmitted disease

Journal

Communicable diseases intelligence (2018)
ISSN: 2209-6051
Titre abrégé: Commun Dis Intell (2018)
Pays: Australia
ID NLM: 101735394

Informations de publication

Date de publication:
21 Aug 2024
Historique:
medline: 21 8 2024
pubmed: 21 8 2024
entrez: 21 8 2024
Statut: epublish

Résumé

The Northern Territory (NT) has the highest rates of sexually transmitted infections (STI) in Australia; however, the local prevalence of

Identifiants

DOI: 10.33321/cdi.2024.48.43 PMID: 39165019
pubmed: 39165019
doi: 10.33321/cdi.2024.48.43
doi:

Substances chimiques

Anti-Bacterial Agents 0
Macrolides 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© Commonwealth of Australia CC BY-NC-ND.

Auteurs

Kate E Proudmore (KE)

Advanced Trainee Infectious Diseases and Acute and General Care Medicine, Royal Darwin Hospital, Darwin; Territory Pathology, Royal Darwin Hospital; Department of Microbiology; Rocklands Drive TIWI NT 0810 Australia.

Manoji Gunathilake (M)

Head of Sexual Health & Blood Borne Virus Unit & Senior Staff Specialist, NT Health, Sexual Health Medicine, Public Health Unit (Centre for Disease Control & Environment Health) Rocklands Drive TIWI NT 0810 Australia.

Lucy C Crawford (LC)

Clinical Microbiologist and Infectious Diseases Physician, Microbiology & Infectious Diseases Directorate, SA Pathology, Royal Adelaide Hospital; Port Rd, Adelaide SA 5000 Australia.

Kevin Freeman (K)

Supervising Scientist, Royal Darwin Hospital, Darwin; Territory Pathology, Royal Darwin Hospital; Department of Microbiology; Rocklands Drive TIWI NT 0810 Australia.

Dimitrios Menouhos (D)

Senior Scientist, Royal Darwin Hospital, Darwin; Territory Pathology, Royal Darwin Hospital; Department of Microbiology; Rocklands Drive TIWI NT 0810 Australia.

Rob W Baird (RW)

Clinical Microbiologist and Director of Pathology, Royal Darwin Hospital, Darwin; Territory Pathology, Royal Darwin Hospital; Department of Microbiology; Rocklands Drive TIWI NT 0810 Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Mycoplasma genitalium retrospective audit of...
questionsmedicales.fr › Bactéries › Bactéries à Gram négatif › Tenericutes › Mycoplasmatales › Mycoplasmataceae › Mycoplasma › Mycoplasma genitalium › Mycoplasma genitalium retrospective audit of...
questionsmedicales.fr › Régions géographiques › Océanie › Australasie › Australie › Territoire du Nord › Mycoplasma genitalium retrospective audit of...
questionsmedicales.fr › Infection › Infections bactériennes et mycoses › Infections bactériennes › Infections bactériennes à Gram négatif › Infections à Mycoplasmatales › Infections à Mycoplasma › Mycoplasma genitalium retrospective audit of...
questionsmedicales.fr › Environnement et santé publique › Santé publique › Méthodes épidémiologiques › Caractéristiques des études épidémiologiques › Études épidémiologiques › Études de cohortes › Études rétrospectives › Mycoplasma genitalium retrospective audit of...
questionsmedicales.fr › Environnement et santé publique › Santé publique › Méthodes épidémiologiques › Collecte de données › Registre civil › Morbidité › Prévalence › Mycoplasma genitalium retrospective audit of...
questionsmedicales.fr › Personnes › Tranches d'âge › Adulte › Mycoplasma genitalium retrospective audit of...
questionsmedicales.fr › Actions chimiques et utilisations › Actions pharmacologiques › Utilisations thérapeutiques › Anti-infectieux › Antibactériens › Mycoplasma genitalium retrospective audit of...
questionsmedicales.fr › Phénomènes physiologiques › Phénomènes pharmacologiques et toxicologiques › Phénomènes pharmacologiques › Résistance aux substances › Résistance microbienne aux médicaments › Résistance bactérienne aux médicaments › Mycoplasma genitalium retrospective audit of...
questionsmedicales.fr › Personnes › Tranches d'âge › Adulte › Adulte d'âge moyen › Mycoplasma genitalium retrospective audit of...
questionsmedicales.fr › États, signes et symptômes pathologiques › Processus pathologiques › Caractéristiques de la maladie › Maladies transmissibles › Maladies sexuellement transmissibles › Mycoplasma genitalium retrospective audit of...
questionsmedicales.fr › Personnes › Tranches d'âge › Adulte › Jeune adulte › Mycoplasma genitalium retrospective audit of...
questionsmedicales.fr › Composés polycycliques › Composés macrocycliques › Polycétides › Macrolides › Mycoplasma genitalium retrospective audit of...